---
title: "Medtronic’s Evolut FX+ TAVI system gains CE mark"
date: "2024-10-24T15:16:48.000Z"
publishedDate: "24 octobre 2024"
summary: "Medtronic has received CE mark for the Evolut FX+ transcatheter aortic valve implantation (TAVI) system for the treatment of symptomatic severe aortic stenosis. This follows the recent US Food and Drug Administration (FDA) approval of the system in March 2024."
importance: ""
sourceUrl: "https://cardiovascularnews.com/medtronics-evolut-fx-tavi-system-gains-ce-mark/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-10-24-medtronics-evolut-fx-tavi-system-gains-ce-mark"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/Medtronic_EV_FX__23_Profile_A-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtronics-evolut-fx-tavi-system-gains-ce-mark/"
---

![Medtronic’s Evolut FX+ TAVI system gains CE mark](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/Medtronic_EV_FX__23_Profile_A-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/medtronics-evolut-fx-tavi-system-gains-ce-mark/*

## L’essentiel

Medtronic has received CE mark for the Evolut FX+ transcatheter aortic valve implantation (TAVI) system for the treatment of symptomatic severe aortic stenosis. This follows the recent US Food and Drug Administration (FDA) approval of the system in March 2024.

## Lien source

https://cardiovascularnews.com/medtronics-evolut-fx-tavi-system-gains-ce-mark/
